Toenail Onychomycosis with or without Diabetes in Canada: Patient Treatment Preferences and Health State Utilities.

"Disclosure VG and MB are employees of Bausch Health, Canada Inc., the manufacturer of Penlac® and Jublia®. Bausch Health, Canada, Inc. was not involved in data collection, analysis, or interpretation of the data. The authors report no other conflicts of interest in this work."

"The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: ATM, GLO, and EP are employees of Broadstreet HEOR, which received funds from Bausch Health, Canada Inc. for this work. The design of this study was developed in consultation with Dr. Steve Mathieu (Dermatologist), who received an honorarium from Bausch Health, Canada Inc. for his expert input. However, Dr. Steve Mathieu did not receive any compensation for the preparation and review of this manuscript."